APA (7th ed.) Citation

Davies, A., Trask, P., Demeter, J., Florschütz, A., Hänel, M., Kinoshita, T., . . . Liu, W. (2020). Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma. Annals of Hematology, 99(12), 2837-2846. https://doi.org/10.1007/s00277-020-04021-6

Chicago Style (17th ed.) Citation

Davies, Andrew, et al. "Health-related Quality of Life in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-based Chemotherapy in Patients with Previously Untreated Advanced Follicular Lymphoma." Annals of Hematology 99, no. 12 (2020): 2837-2846. https://doi.org/10.1007/s00277-020-04021-6.

MLA (9th ed.) Citation

Davies, Andrew, et al. "Health-related Quality of Life in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-based Chemotherapy in Patients with Previously Untreated Advanced Follicular Lymphoma." Annals of Hematology, vol. 99, no. 12, 2020, pp. 2837-2846, https://doi.org/10.1007/s00277-020-04021-6.